Published in Antimicrob Agents Chemother on September 10, 2012
Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii. J Med Chem (2013) 0.87
Galleria mellonella as a model host for human pathogens: recent studies and new perspectives. Virulence (2012) 0.87
Role of Iron Uptake Systems in Pseudomonas aeruginosa Virulence and Airway Infection. Infect Immun (2016) 0.84
Iron and Acinetobacter baumannii Biofilm Formation. Pathogens (2014) 0.82
Gallium nitrate is efficacious in murine models of tuberculosis and inhibits key bacterial Fe-dependent enzymes. Antimicrob Agents Chemother (2013) 0.82
Drug repurposing as an alternative for the treatment of recalcitrant bacterial infections. Front Microbiol (2015) 0.82
Antimicrobial Activity of Gallium Protoporphyrin IX against Acinetobacter baumannii Strains Displaying Different Antibiotic Resistance Phenotypes. Antimicrob Agents Chemother (2015) 0.79
Pyoverdine and proteases affect the response of Pseudomonas aeruginosa to gallium in human serum. Antimicrob Agents Chemother (2015) 0.78
Induction of heme oxygenase-1 contributes to survival of Mycobacterium abscessus in human macrophages-like THP-1 cells. Redox Biol (2015) 0.78
Genetic Regulation of Virulence and Antibiotic Resistance in Acinetobacter baumannii. Genes (Basel) (2016) 0.78
Treatment for patients with multidrug resistant Acinetobacter baumannii pulmonary infection. Exp Ther Med (2016) 0.77
Siderophores in Iron Metabolism: From Mechanism to Therapy Potential. Trends Mol Med (2016) 0.76
Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus. Antimicrob Agents Chemother (2015) 0.76
Activity of Gallium Meso- and Protoporphyrin IX against Biofilms of Multidrug-Resistant Acinetobacter baumannii Isolates. Pharmaceuticals (Basel) (2016) 0.76
Current Trends in Development of Liposomes for Targeting Bacterial Biofilms. Pharmaceutics (2016) 0.75
An In Vitro Comparison of PMMA and Calcium Sulfate as Carriers for the Local Delivery of Gallium(III) Nitrate to Staphylococcal Infected Surgical Sites. Biomed Res Int (2016) 0.75
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options. Front Cell Infect Microbiol (2017) 0.75
Acinetobacter baumannii biofilm formation in Human serum and disruption by gallium. Antimicrob Agents Chemother (2016) 0.75
Evaluation of Gallium Citrate Formulations against a Multidrug-Resistant Strain of Klebsiella pneumoniae in a Murine Wound Model of Infection. Antimicrob Agents Chemother (2015) 0.75
A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Sci Rep (2017) 0.75
Universal chemical assay for the detection and determination of siderophores. Anal Biochem (1987) 18.60
Dose translation from animal to human studies revisited. FASEB J (2007) 15.67
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev (1996) 13.25
An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol (2007) 10.18
Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem (2007) 8.60
Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother (2007) 7.84
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis (2006) 7.36
New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev (2007) 4.62
Promoters in the nodulation region of the Rhizobium leguminosarum Sym plasmid pRL1JI. Plant Mol Biol (1987) 4.13
Fur regulon in gram-negative bacteria. Identification and characterization of new iron-regulated Escherichia coli genes by a fur titration assay. J Mol Biol (1994) 4.09
Comparative analysis of Acinetobacters: three genomes for three lifestyles. PLoS One (2008) 3.94
Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol (2001) 3.49
Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group. Antimicrob Agents Chemother (2008) 3.24
Functional specialization within the Fur family of metalloregulators. Biometals (2007) 2.85
Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol (2004) 2.81
Stoichiometric and site characteristics of the binding of iron to human transferrin. J Biol Chem (1978) 2.63
Iron availability and infection. Biochim Biophys Acta (2008) 2.56
The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace. Front Microbiol (2012) 2.45
Detection, isolation, and characterization of siderophores. Methods Enzymol (1994) 2.30
The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J Clin Invest (2007) 2.26
Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents (2011) 2.19
Long-term predominance of two pan-European clones among multi-resistant Acinetobacter baumannii strains in the Czech Republic. J Med Microbiol (2004) 1.93
Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother (2009) 1.86
Mechanisms of therapeutic activity for gallium. Pharmacol Rev (1998) 1.72
In vitro antibacterial activities of tigecycline in combination with other antimicrobial agents determined by chequerboard and time-kill kinetic analysis. J Antimicrob Chemother (2006) 1.68
Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii. Antimicrob Agents Chemother (2009) 1.64
Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice. Infect Immun (2012) 1.57
Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS One (2011) 1.56
Recent insights into iron import by bacteria. Curr Opin Chem Biol (2011) 1.51
Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. Infect Immun (2000) 1.49
Resistance of planktonic and biofilm-grown Burkholderia cepacia complex isolates to the transition metal gallium. J Antimicrob Chemother (2008) 1.48
Iron-regulated salicylate synthesis by Pseudomonas spp. J Gen Microbiol (1993) 1.45
Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain. Microbes Infect (2007) 1.44
The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent. Proc Natl Acad Sci U S A (2008) 1.41
Acinetobacter infection--an emerging threat to human health. IUBMB Life (2011) 1.39
Gallium maltolate treatment eradicates Pseudomonas aeruginosa infection in thermally injured mice. Antimicrob Agents Chemother (2009) 1.20
Treatment of Acinetobacter infections. Expert Opin Pharmacother (2010) 1.18
Distribution of intrinsic plasmid replicase genes and their association with carbapenem-hydrolyzing class D beta-lactamase genes in European clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother (2011) 1.17
Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy). Clin Microbiol Infect (2009) 1.17
Gallium in cancer treatment. Crit Rev Oncol Hematol (2002) 1.16
Genome-assisted identification of putative iron-utilization genes in Acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates. Res Microbiol (2010) 1.12
The genomics of Acinetobacter baumannii: insights into genome plasticity, antimicrobial resistance and pathogenicity. IUBMB Life (2011) 1.07
Antibacterial activities of iron chelators against common nosocomial pathogens. Antimicrob Agents Chemother (2012) 1.05
In vitro and in vivo biological activities of iron chelators and gallium nitrate against Acinetobacter baumannii. Antimicrob Agents Chemother (2012) 1.04
In vitro activity of the siderophore monosulfactam BAL30072 against meropenem-non-susceptible Acinetobacter baumannii. J Antimicrob Chemother (2012) 1.03
Gallium disrupts iron uptake by intracellular and extracellular Francisella strains and exhibits therapeutic efficacy in a murine pulmonary infection model. Antimicrob Agents Chemother (2009) 1.03
The Pseudomonas aeruginosa pyochelin-iron uptake pathway and its metal specificity. J Bacteriol (2009) 1.01
Exchange of iron by gallium in siderophores. Biochemistry (1986) 0.95
New insights into the metal specificity of the Pseudomonas aeruginosa pyoverdine-iron uptake pathway. Environ Microbiol (2009) 0.93
Characterization of the Acinetobacter baumannii growth phase-dependent and serum responsive transcriptomes. FEMS Immunol Med Microbiol (2012) 0.91
In vitro activity of gallium maltolate against Staphylococci in logarithmic, stationary, and biofilm growth phases: comparison of conventional and calorimetric susceptibility testing methods. Antimicrob Agents Chemother (2009) 0.88
In vitro antimicrobial activity of gallium maltolate against virulent Rhodococcus equi. Vet Microbiol (2010) 0.86
In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother (2008) 0.84
The antibacterial activity of Ga3+ is influenced by ligand complexation as well as the bacterial carbon source. Antimicrob Agents Chemother (2011) 0.83
Gallium nitrate for acute treatment of cancer-related hypercalcemia: clinicopharmacological and dose response analysis. Cancer Res (1986) 0.83
Report of the Consensus Conference on Antibiotic Resistance; Prevention and Control (ARPAC). Clin Microbiol Infect (2005) 0.83
Identification and characterization of an outer membrane receptor gene in Acinetobacter baumannii required for utilization of desferricoprogen, rhodotorulic acid, and desferrioxamine B as xenosiderophores. Biol Pharm Bull (2012) 0.80
Antimicrobial activity of gallium nitrate against Mycobacterium avium subsp. paratuberculosis in neonatal calves. J Vet Intern Med (2011) 0.80
Ga3+ as a mechanistic probe in Fe3+ transport: characterization of Ga3+ interaction with FbpA. J Biol Inorg Chem (2008) 0.79
Iron contributes to the antibacterial functions of the haemolymph of Galleria mellonella. J Insect Physiol (2002) 0.78
Evaluation of the effect of gallium maltolate on fecal Salmonella shedding in cattle. J Food Prot (2011) 0.76
Whole-genome pyrosequencing of an epidemic multidrug-resistant Acinetobacter baumannii strain belonging to the European clone II group. Antimicrob Agents Chemother (2008) 3.24
Pyoverdine siderophores: from biogenesis to biosignificance. Trends Microbiol (2006) 2.19
Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. Mol Biol Cell (2004) 2.07
Functional characterization and regulation of gadX, a gene encoding an AraC/XylS-like transcriptional activator of the Escherichia coli glutamic acid decarboxylase system. J Bacteriol (2002) 1.87
Acinetobacter baumannii: evolution of a global pathogen. Pathog Dis (2014) 1.70
Characterization of pABVA01, a plasmid encoding the OXA-24 carbapenemase from Italian isolates of Acinetobacter baumannii. Antimicrob Agents Chemother (2009) 1.64
Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS One (2011) 1.56
Anthrax toxin: a tripartite lethal combination. FEBS Lett (2002) 1.54
Burkholderia cepacia complex species: health hazards and biotechnological potential. Trends Microbiol (2006) 1.49
Common themes and variations in the rhodanese superfamily. IUBMB Life (2007) 1.46
Molecular basis of pyoverdine siderophore recycling in Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2009) 1.40
Hemoglobin and heme scavenging. IUBMB Life (2005) 1.34
In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii. Ann Clin Microbiol Antimicrob (2009) 1.24
Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central Italy. J Antimicrob Chemother (2010) 1.23
A novel clinical prognostic score incorporating the number of resected lymph-nodes to predict recurrence and survival in non-small-cell lung cancer. Lung Cancer (2009) 1.17
The serine protease HtrA1 is a novel prognostic factor for human mesothelioma. Pharmacogenomics (2008) 1.15
Analysis of the periplasmic proteome of Pseudomonas aeruginosa, a metabolically versatile opportunistic pathogen. Proteomics (2009) 1.14
Molecular epidemiology of a Pseudomonas aeruginosa hospital outbreak driven by a contaminated disinfectant-soap dispenser. PLoS One (2011) 1.14
Genome-assisted identification of putative iron-utilization genes in Acinetobacter baumannii and their distribution among a genotypically diverse collection of clinical isolates. Res Microbiol (2010) 1.12
Repurposing the antimycotic drug flucytosine for suppression of Pseudomonas aeruginosa pathogenicity. Proc Natl Acad Sci U S A (2013) 1.12
Composite integron array generated by insertion of an ORF341-type integron within a Tn21-like element. Microb Drug Resist (2002) 1.11
S-palmitoylation modulates human estrogen receptor-alpha functions. Biochem Biophys Res Commun (2004) 1.10
Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78. BMC Infect Dis (2013) 1.08
The genomics of Acinetobacter baumannii: insights into genome plasticity, antimicrobial resistance and pathogenicity. IUBMB Life (2011) 1.07
Intracellular levels and activity of PvdS, the major iron starvation sigma factor of Pseudomonas aeruginosa. Mol Microbiol (2007) 1.05
Mycobacterial truncated hemoglobins: from genes to functions. Gene (2007) 0.99
Solitary fibrous tumor of the liver. J Hepatobiliary Pancreat Surg (2005) 0.99
Transcriptional control of the pvdS iron starvation sigma factor gene by the master regulator of sulfur metabolism CysB in Pseudomonas aeruginosa. Environ Microbiol (2010) 0.98
Identification of variable-number tandem-repeat (VNTR) sequences in Acinetobacter baumannii and interlaboratory validation of an optimized multiple-locus VNTR analysis typing scheme. J Clin Microbiol (2010) 0.97
Identification of variable-number tandem-repeat (VNTR) sequences in Legionella pneumophila and development of an optimized multiple-locus VNTR analysis typing scheme. J Clin Microbiol (2007) 0.96
New life for an old drug: the anthelmintic drug niclosamide inhibits Pseudomonas aeruginosa quorum sensing. Antimicrob Agents Chemother (2012) 0.94
Determination of SGK1 mRNA in non-small cell lung cancer samples underlines high expression in squamous cell carcinomas. J Exp Clin Cancer Res (2012) 0.94
Histological in vitro evaluation of the effects of Er:YAG laser on oral soft tissues. Lasers Med Sci (2011) 0.94
Identification of clinically relevant yeast species by DNA sequence analysis of the D2 variable region of the 25-28S rRNA gene. Mycoses (2008) 0.94
Cell-surface signaling in Pseudomonas: stress responses, iron transport, and pathogenicity. FEMS Microbiol Rev (2014) 0.94
Promises and failures of gallium as an antibacterial agent. Future Microbiol (2014) 0.94
The Gac/Rsm and cyclic-di-GMP signalling networks coordinately regulate iron uptake in Pseudomonas aeruginosa. Environ Microbiol (2013) 0.94
Evidence of diversity among epidemiologically related carbapenemase-producing Acinetobacter baumannii strains belonging to international clonal lineage II. J Clin Microbiol (2012) 0.94
Effect of acid adaptation on the fate of Listeria monocytogenes in THP-1 human macrophages activated by gamma interferon. Infect Immun (2002) 0.93
Involvement of Pseudomonas aeruginosa rhodanese in protection from cyanide toxicity. Appl Environ Microbiol (2006) 0.93
Involvement of AlgQ in transcriptional regulation of pyoverdine genes in Pseudomonas aeruginosa PAO1. J Bacteriol (2005) 0.92
The bacterial aetiology of rosy discoloration of ancient wall paintings. Environ Microbiol (2007) 0.91
Diversity of Bacillus anthracis strains in Georgia and of vaccine strains from the former Soviet Union. Appl Environ Microbiol (2006) 0.91
Fatty acid synthase is a marker of increased risk of recurrence in endometrial carcinoma. Gynecol Oncol (2004) 0.91
Membrane-association determinants of the omega-amino acid monooxygenase PvdA, a pyoverdine biosynthetic enzyme from Pseudomonas aeruginosa. Microbiology (2008) 0.91
Enzymatic detoxification of cyanide: clues from Pseudomonas aeruginosa Rhodanese. J Mol Microbiol Biotechnol (2008) 0.91
Repurposing of gallium-based drugs for antibacterial therapy. Biofactors (2014) 0.89
Expression of L-ornithine Ndelta-oxygenase (PvdA) in fluorescent Pseudomonas species: an immunochemical and in silico study. Biochem Biophys Res Commun (2004) 0.89
Tissue microarray analysis of FAS, Bcl-2, Bcl-x, ER, PgR, Hsp60, p53 and Her2-neu in breast carcinoma. Anticancer Res (2006) 0.89
Bone damage induced by different cutting instruments--an in vitro study. Braz Dent J (2009) 0.88
Intracellular presence of insulin and its phosphorylated receptor in non-small cell lung cancer. J Cell Physiol (2009) 0.88
The dual personality of iron chelators: growth inhibitors or promoters? Antimicrob Agents Chemother (2013) 0.88
High-level tolerance to triclosan may play a role in Pseudomonas aeruginosa antibiotic resistance in immunocompromised hosts: evidence from outbreak investigation. BMC Res Notes (2012) 0.88
HPV prevalence among healthy Italian male sexual partners of women with cervical HPV infection. J Med Virol (2008) 0.87
Inactivation of parasite cysteine proteinases by the NO-donor 4-(phenylsulfonyl)-3-((2-(dimethylamino)ethyl)thio)-furoxan oxalate. Biochim Biophys Acta (2004) 0.86
Different responses of pyoverdine genes to autoinduction in Pseudomonas aeruginosa and the group Pseudomonas fluorescens-Pseudomonas putida. Appl Environ Microbiol (2002) 0.86
EGFR molecular profiling in advanced NSCLC: a prospective phase II study in molecularly/clinically selected patients pretreated with chemotherapy. J Thorac Oncol (2012) 0.86
Regulation of the Pseudomonas aeruginosa toxA, regA and ptxR genes by the iron-starvation sigma factor PvdS under reduced levels of oxygen. Microbiology (2007) 0.86
Scavenging of reactive nitrogen species by mycobacterial truncated hemoglobins. Methods Enzymol (2008) 0.85
A multitask biosensor for micro-volumetric detection of N-3-oxo-dodecanoyl-homoserine lactone quorum sensing signal. Biosens Bioelectron (2011) 0.84
In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother (2008) 0.84
Strategy for identification of Bacillus cereus and Bacillus thuringiensis strains closely related to Bacillus anthracis. Appl Environ Microbiol (2006) 0.84
Microbial community structure and dynamics of dark fire-cured tobacco fermentation. Appl Environ Microbiol (2006) 0.83
Melanoma molecular classes and prognosis in the postgenomic era. Lancet Oncol (2012) 0.83
Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease. Clin Diagn Lab Immunol (2002) 0.83
CO sniffing through heme-based sensor proteins. IUBMB Life (2004) 0.83
Truncated hemoglobin GlbO from Mycobacterium leprae alleviates nitric oxide toxicity. Microb Pathog (2006) 0.83
Analysis of guazatine mixture by LC and LC-MS and antimycotic activity determination of principal components. J Pharm Biomed Anal (2006) 0.82
Inhibition of Azotobacter vinelandii rhodanese by NO-donors. Biochem Biophys Res Commun (2003) 0.82
Synthesis of new linear guanidines and macrocyclic amidinourea derivatives endowed with high antifungal activity against Candida spp. and Aspergillus spp. J Med Chem (2009) 0.81
Role and predictive strength of transglutaminase type 2 expression in premalignant lesions of the cervix. Mod Pathol (2011) 0.81
A putative de-N-acetylase of the PIG-L superfamily affects fluoroquinolone tolerance in Pseudomonas aeruginosa. Pathog Dis (2014) 0.81
Subcellular localization of the pyoverdine biogenesis machinery of Pseudomonas aeruginosa: a membrane-associated "siderosome". FEBS Lett (2013) 0.81
Nitric oxide scavenging by Mycobacterium leprae GlbO involves the formation of the ferric heme-bound peroxynitrite intermediate. Biochem Biophys Res Commun (2005) 0.81
Catalytic peroxidation of nitrogen monoxide and peroxynitrite by globins. IUBMB Life (2009) 0.81
A new transcriptional repressor of the pseudomonas aeruginosa quorum sensing receptor gene lasR. PLoS One (2013) 0.81
Characterization of a rhodanese from the cyanogenic bacterium Pseudomonas aeruginosa. Biochem Biophys Res Commun (2004) 0.81
A melanoma immune response signature including Human Leukocyte Antigen-E. Pigment Cell Melanoma Res (2013) 0.81
Peroxynitrite scavenging by ferrous truncated hemoglobin GlbO from Mycobacterium leprae. Biochem Biophys Res Commun (2006) 0.80